ARCHIVES

Arzerra Promising For Heavily Pre-Treated CLL Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Solomon Gard Loses Final Cancer Battle

February 12, 1982

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005

In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center

August 4, 1995

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012